Uas Pharmaceuticals (India) Private Limited

Uas Pharmaceuticals (India) Private Limited - consumer goods in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51397DL2007PTC214233 Incorporated 20 March 2007 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company consumer goods
Revenue · FY 2019
₹1.86 Cr
▼ 0.40% YoY
Net loss · FY 2019
₹1.44 Cr
Net margin -77.5%
EBITDA · FY 2019
-₹1.43 Cr
EBITDA margin -76.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
19 yrs
Est. 2007
Employees · EPFO
9
Provident fund records
Directors on board
4
As per MCA filings

About Uas Pharmaceuticals (India) Private Limited

Data last updated:

Uas Pharmaceuticals (India) Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Uas Pharmaceuticals Pty Ltd. It operates in the health and beauty retail and distribution segment of the consumer goods sector. It was incorporated on 20 March 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2007PTC214233. The company has 2 GST registrations on record, none of which is active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Ajit Kumar Seth and Anuj Seth.

Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at A 9 Lsc Sarai Rohilla Padam Nagar, New Delhi, Delhi, India – 110007.

As per the financials filed for FY 2019, the company reported a revenue of ₹1.86 Cr. For the same year it recorded a net loss of ₹1.44 Cr (net margin -77.5%) and EBITDA of -₹1.43 Cr (EBITDA margin -76.8%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 3% over five years.

The company has about 9 employees on its provident fund (EPFO) records.

Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uaspharma.in.

Company details

CIN U51397DL2007PTC214233
Registration Number 214233
Incorporation Date 20 March 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company Uas Pharmaceuticals Pty Ltd
Compliance Status Active Compliant

CIN history

Uas Pharmaceuticals (India) has one previous CIN (Corporate Identification Number): U51397TN2007PTC062782. The current CIN is U51397DL2007PTC214233, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51397DL2007PTC214233Current
U51397TN2007PTC062782Previous

Contact details

Uas Pharmaceuticals (India) Private Limited's registered office is in New Delhi, Delhi. Its website is uaspharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    A 9 Lsc Sarai Rohilla Padam Nagar, New Delhi, Delhi, India – 110007
  • Industry
    Consumer Goods, Health & Beauty Retail & Distribution

To see the full contact details of Uas Pharmaceuticals (India) Private Limited, buy the company report.

Comprehensive company report
Uas Pharmaceuticals (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activities of Uas Pharmaceuticals (India) are trade and support service to organizations. In detail, this covers wholesale trading and other support services to organizations. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Uas Pharmaceuticals (India) Private Limited, buy the company report.

Financials of Uas Pharmaceuticals (India) Private Limited

FY 2019 filings available

Uas Pharmaceuticals (India) Private Limited reported revenue of ₹1.86 Cr for FY 2019.

Revenue · FY 2019
₹1.86 Cr
Net loss · FY 2019
₹1.44 Cr margin -77.5%
EBITDA · FY 2019
-₹1.43 Cr margin -76.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 7%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 25%
5 years · compounded
▼ 7%

Revenue has grown at a compounded annual rate (CAGR) of 3% over five years. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1.86 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.43 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.44 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-76.8%
Net Profit Margin-77.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Uas Pharmaceuticals (India) Private Limited, buy the company report.

Board of directors of Uas Pharmaceuticals (India) Private Limited

Uas Pharmaceuticals (India) has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashi DayalAdditional Director31 Mar 201511 Years 7 MonthsCurrent
Ajit Kumar SethDirector20 Mar 200719 Years 7 MonthsCurrent
Anuj SethDirector09 Jun 200917 Years 5 MonthsCurrent
Urvashi SethDirector20 Mar 200719 Years 7 MonthsCurrent

Peer comparison

Uas Pharmaceuticals (India) Private Limited is compared with the 6 companies closest to it by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pashupati Chemicals & Pharmaceuticals Limited₹1.87 Cr (FY 2024)-23.0%Kolkata, West Bengal, India
Frankfurt Pharmaceuticals Private Limited₹1.87 Cr (FY 2025)10.0%New Delhi, Delhi, India
Astorion Pharmaceuticals Private Limited₹1.87 Cr (FY 2025)16.0%Hyderabad, Telangana, India
Leewell Pharmaceuticals Private Limited₹1.86 Cr (FY 2025)94.0%Hyderabad, Telangana, India
Uas Pharmaceuticals (India) Private Limitedthis company₹1.86 Cr (FY 2019)-₹1.44 Cr-77.5%9New Delhi, Delhi, India
Catholicon Pharmaceuticals Private Limited₹1.86 Cr (FY 2025)-19.0%Chandigarh, India
Precise Pharmaceuticals Private Limited₹1.85 Cr (FY 2024)7.0%Ludhiana, Punjab, India

To see the full peer comparison of Uas Pharmaceuticals (India) Private Limited, buy the company report.

Auditor

Uas Pharmaceuticals (India) Private Limited is audited by H U M S & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
H U M S & ASSOCIATESFY 2019022230N

Shareholding

The shareholding of Uas Pharmaceuticals (India) Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Uas Pharmaceuticals (India) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Uas Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Uas Pharmaceuticals (India) Private Limited has a workforce of 9 employees on its EPFO records as of Feb 2020, across 1 active EPFO establishment.

Employee count
9
Active EPFO establishments
1
Employee growth
-50%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2019-209
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Uas Pharmaceuticals (India) Private Limited, buy the company report.

GST

Uas Pharmaceuticals (India) has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of Uas Pharmaceuticals (India) Private Limited, buy the company report.

Recent activity

Uas Pharmaceuticals (India) Private Limited has 7 board changes on record since 2007: 4 appointments and 3 cessations. The latest: Neha Dayal ceased to be Director on 18 Aug 2017.

AGM
Uas Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Filing
Uas Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi.
Ceased
Neha Dayal ceased to be Director.
Ceased
Ashi Dayal ceased to be Additional Director.
Appointed
Ashi Dayal was appointed as Additional Director.
Appointed
Anuj Seth was appointed as Director.
Ceased
Pramod Kumar Mohan ceased to be Director.
Appointed
Ajit Kumar Seth was appointed as Director.
Appointed
Urvashi Seth was appointed as Director.
Incorporation
20 Mar 2007
Uas Pharmaceuticals (India) Private Limited was registered on 20 Mar 2007 with Roc Delhi & aged 19 years 7 months as per MCA records.

Frequently asked questions

Uas Pharmaceuticals (India) is an active private limited company based in New Delhi, Delhi, India. The company works in health and beauty retail and distribution, within the consumer goods industry. It was incorporated on 20 March 2007 (19+ years old) and is registered under CIN U51397DL2007PTC214233.

Uas Pharmaceuticals (India) has 4 current directors:

The latest financial statements of Uas Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.

No. Uas Pharmaceuticals (India) has 2 GST registrations on record and all of them are cancelled or inactive.

The CIN (Corporate Identification Number) of Uas Pharmaceuticals (India) is U51397DL2007PTC214233. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Uas Pharmaceuticals (India) has 6 court cases on record: 3 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.

Uas Pharmaceuticals (India) was incorporated on 20 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Uas Pharmaceuticals (India) by revenue are Pashupati Chemicals & Pharmaceuticals Limited, Frankfurt Pharmaceuticals Private Limited, Astorion Pharmaceuticals Private Limited, Leewell Pharmaceuticals Private Limited, Catholicon Pharmaceuticals Private Limited and 1 more, all in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Neha Dayal ceased to be Director on 18 Aug 2017. Ashi Dayal ceased to be Additional Director on 24 Aug 2015. Ashi Dayal was appointed as Additional Director on 31 Mar 2015. Uas Pharmaceuticals (India) has 7 board changes on record in total.

Uas Pharmaceuticals (India) can be reached through the website uaspharma.in. Its registered office is in New Delhi, Delhi, India.

The registered office of Uas Pharmaceuticals (India) is at A 9 Lsc Sarai Rohilla Padam Nagar, New Delhi, Delhi, India – 110007.